Some local officials want to hamper needle exchange programs that public health officials say are crucial to reducing the spread of blood-borne diseases.
Every cell in the body makes both RNA and peptides. But what emerges here is not just a story about molecules, but about trust ...
Inside a storage room at the Clark County Health Department are boxes with taped-on signs reading, “DO NOT USE.” The supplies ...
Panelists discuss how faricimab and aflibercept 8 mg compare in drying and durability and how clinicians manage IOP ...
The FDA approved Lerochol, a monthly PCSK9 inhibitor, for adults with hypercholesterolemia to reduce LDL-C levels alongside diet and exercise.
Enable Injections, Inc. (“Enable”), a healthcare innovation company developing and manufacturing the enFuse® On-Body Delivery System, today announced that the EMPAVELI® Injector, based on enFuse ...
Enable Injections, Inc. ("Enable"), a healthcare innovation company developing and manufacturing the enFuse(R) On-Body Delivery System, today announced that the EMPAVELI(R) Injector, based on enFuse ...
Samsung Bioepis Co. Ltd. has announced the marketing approval of Ustekinumab BS Subcutaneous Injection 45mg Syringes 'NIPRO', ...
Celltrion, Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion of autoinjector of SteQeyma (TM), a ...
INDIANAPOLIS — Former Indiana Attorney General Curtis Hill criticized the state’s syringe exchange program during a recent podcast interview, arguing that the initiative fails to curb drug overdoses ...
The global auto-injectors market is rapidly evolving, emerging as one of the most dynamic segments of medical devices and ...
The FDA approved a new 300 mg/2 mL dose of Celltrion’s omalizumab biosimilar, Omlyclo, for the treatment of four allergic and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback